Response to Comments: Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II prothrombin, and MTHFR)

This A54586 document is a response-to-comments record for draft policy DL35984 about testing for hypercoagulability (Factor V Leiden, Factor II prothrombin, MTHFR) and does not define coverage criteria itself. For actionable indications, limitations, documentation requirements, and frequency limits for these tests, review DL35984 or the final policy derived from that draft.

"This document records comments received on draft policy DL35984 concerning testing for hypercoagulability/thrombophilia (Factor V Leiden, Factor II prothrombin, and MTHFR) and does not itself speci..."

Sign up to see full coverage criteria, indications, and limitations.